Last Andrew J. has filed 36 insider transactions across 2 companies since April 2023.
Most recent transaction: a grant/award of 35000 shares of Insight Molecular Diagnostics Inc. ($IMDX) on July 01, 2025.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 1, 2025 | Insight Molecular Diagnostics Inc. | $IMDX | Last Andrew J. | Director | A | Common Stock, no par value | 35000 | $0.00 | 39,509.0000 | 13,071,000 | 776.23% | 0.27% |
| Sept. 6, 2024 | BIO-RAD LABORATORIES, INC. | $BIO | Last Andrew J. | EVP, Chief Operating Officer | S | Bio-Rad A Common Stock | 3000 | $329.94 | 7,559.4501 | 29,209,000 | 28.41% | 0.01% |
| Sept. 6, 2024 | BIO-RAD LABORATORIES, INC. | $BIO | Last Andrew J. | EVP, Chief Operating Officer | M | Non-Qualified Stock Option (right to buy) | 3000 | $0.00 | 0.0000 | 29,209,000 | 100.00% | 0.01% |
| Sept. 6, 2024 | BIO-RAD LABORATORIES, INC. | $BIO | Last Andrew J. | EVP, Chief Operating Officer | M | Bio-Rad A Common Stock | 3000 | $299.24 | 10,559.4501 | 29,209,000 | 39.69% | 0.01% |
| Sept. 1, 2024 | BIO-RAD LABORATORIES, INC. | $BIO | Last Andrew J. | EVP, Chief Operating Officer | F | Bio-Rad A Common Stock | 440 | $337.32 | 6,802.4501 | 29,209,000 | 6.08% | 0.00% |
| Sept. 1, 2024 | BIO-RAD LABORATORIES, INC. | $BIO | Last Andrew J. | EVP, Chief Operating Officer | M | Bio-Rad A Common Stock | 633 | $0.00 | 7,435.4501 | 29,209,000 | 9.31% | 0.00% |
| Sept. 1, 2024 | BIO-RAD LABORATORIES, INC. | $BIO | Last Andrew J. | EVP, Chief Operating Officer | F | Bio-Rad A Common Stock | 321 | $337.32 | 7,114.4501 | 29,209,000 | 4.32% | 0.00% |
| Sept. 2, 2024 | BIO-RAD LABORATORIES, INC. | $BIO | Last Andrew J. | EVP, Chief Operating Officer | M | Bio-Rad A Common Stock | 903 | $0.00 | 8,017.4501 | 29,209,000 | 12.69% | 0.00% |
| Sept. 1, 2024 | BIO-RAD LABORATORIES, INC. | $BIO | Last Andrew J. | EVP, Chief Operating Officer | M | Restricted Stock Units | 1252 | $0.00 | 3,756.0000 | 29,209,000 | 25.00% | 0.00% |
| Sept. 1, 2024 | BIO-RAD LABORATORIES, INC. | $BIO | Last Andrew J. | EVP, Chief Operating Officer | M | Restricted Stock Units | 867 | $0.00 | 1,735.0000 | 29,209,000 | 33.32% | 0.00% |
| Sept. 1, 2024 | BIO-RAD LABORATORIES, INC. | $BIO | Last Andrew J. | EVP, Chief Operating Officer | M | Restricted Stock Units | 633 | $0.00 | 633.0000 | 29,209,000 | 50.00% | 0.00% |
| Sept. 2, 2024 | BIO-RAD LABORATORIES, INC. | $BIO | Last Andrew J. | EVP, Chief Operating Officer | M | Restricted Stock Units | 903 | $0.00 | 0.0000 | 29,209,000 | 100.00% | 0.00% |
| Sept. 2, 2024 | BIO-RAD LABORATORIES, INC. | $BIO | Last Andrew J. | EVP, Chief Operating Officer | F | Bio-Rad A Common Stock | 458 | $337.32 | 7,559.4501 | 29,209,000 | 5.71% | 0.00% |
| Sept. 1, 2024 | BIO-RAD LABORATORIES, INC. | $BIO | Last Andrew J. | EVP, Chief Operating Officer | M | Bio-Rad A Common Stock | 1252 | $0.00 | 7,010.4501 | 29,209,000 | 21.74% | 0.00% |
| Sept. 1, 2024 | BIO-RAD LABORATORIES, INC. | $BIO | Last Andrew J. | EVP, Chief Operating Officer | F | Bio-Rad A Common Stock | 635 | $337.32 | 6,375.4501 | 29,209,000 | 9.06% | 0.00% |
| Sept. 1, 2024 | BIO-RAD LABORATORIES, INC. | $BIO | Last Andrew J. | EVP, Chief Operating Officer | M | Bio-Rad A Common Stock | 867 | $0.00 | 7,242.4501 | 29,209,000 | 13.60% | 0.00% |
| July 1, 2024 | Insight Molecular Diagnostics Inc. | $IMDX | Last Andrew J. | Director | A | Option to Purchase Common Stock | 30000 | $0.00 | 30,000.0000 | 7,651,000 | 9999.99% | 0.39% |
| April 29, 2024 | BIO-RAD LABORATORIES, INC. | $BIO | Last Andrew J. | EVP, Chief Operating Officer | F | Bio-Rad A Common Stock | 357 | $277.11 | 5,719.8881 | 29,209,000 | 5.87% | 0.00% |
| April 29, 2024 | BIO-RAD LABORATORIES, INC. | $BIO | Last Andrew J. | EVP, Chief Operating Officer | M | Restricted Stock Units | 1000 | $0.00 | 0.0000 | 29,209,000 | 100.00% | 0.00% |
| April 29, 2024 | BIO-RAD LABORATORIES, INC. | $BIO | Last Andrew J. | EVP, Chief Operating Officer | M | Bio-Rad A Common Stock | 1000 | $0.00 | 6,076.8881 | 29,209,000 | 19.70% | 0.00% |
| March 8, 2024 | BIO-RAD LABORATORIES, INC. | $BIO | Last Andrew J. | EVP, Chief Operating Officer | A | Non-Qualified Stock Option (right to buy) | 5891 | $0.00 | 5,891.0000 | 29,209,000 | 9999.99% | 0.02% |
| Sept. 1, 2023 | BIO-RAD LABORATORIES, INC. | $BIO | Last Andrew J. | EVP, Chief Operating Officer | M | Bio-Rad A Common Stock | 867 | $0.00 | 4,660.6001 | 29,785,000 | 22.85% | 0.00% |
| Sept. 1, 2023 | BIO-RAD LABORATORIES, INC. | $BIO | Last Andrew J. | EVP, Chief Operating Officer | F | Bio-Rad A Common Stock | 430 | $394.60 | 4,230.6001 | 29,785,000 | 9.23% | 0.00% |
| Sept. 1, 2023 | BIO-RAD LABORATORIES, INC. | $BIO | Last Andrew J. | EVP, Chief Operating Officer | M | Bio-Rad A Common Stock | 633 | $0.00 | 4,863.6001 | 29,785,000 | 14.96% | 0.00% |
| Sept. 1, 2023 | BIO-RAD LABORATORIES, INC. | $BIO | Last Andrew J. | EVP, Chief Operating Officer | F | Bio-Rad A Common Stock | 279 | $394.60 | 4,584.6001 | 29,785,000 | 5.74% | 0.00% |
| Sept. 2, 2023 | BIO-RAD LABORATORIES, INC. | $BIO | Last Andrew J. | EVP, Chief Operating Officer | M | Bio-Rad A Common Stock | 903 | $0.00 | 5,487.6001 | 29,785,000 | 19.70% | 0.00% |
| Sept. 2, 2023 | BIO-RAD LABORATORIES, INC. | $BIO | Last Andrew J. | EVP, Chief Operating Officer | F | Bio-Rad A Common Stock | 448 | $394.60 | 5,039.6001 | 29,785,000 | 8.16% | 0.00% |
| Sept. 1, 2023 | BIO-RAD LABORATORIES, INC. | $BIO | Last Andrew J. | EVP, Chief Operating Officer | A | Restricted Stock Units | 5008 | $0.00 | 5,008.0000 | 29,785,000 | 9999.99% | 0.02% |
| Sept. 1, 2023 | BIO-RAD LABORATORIES, INC. | $BIO | Last Andrew J. | EVP, Chief Operating Officer | M | Restricted Stock Units | 867 | $0.00 | 2,602.0000 | 29,785,000 | 24.99% | 0.00% |
| Sept. 1, 2023 | BIO-RAD LABORATORIES, INC. | $BIO | Last Andrew J. | EVP, Chief Operating Officer | M | Restricted Stock Units | 633 | $0.00 | 1,266.0000 | 29,785,000 | 33.33% | 0.00% |
| Sept. 2, 2023 | BIO-RAD LABORATORIES, INC. | $BIO | Last Andrew J. | EVP, Chief Operating Officer | M | Restricted Stock Units | 903 | $0.00 | 903.0000 | 29,785,000 | 50.00% | 0.00% |
| June 23, 2023 | Insight Molecular Diagnostics Inc. | $IMDX | Last Andrew J. | Director | A | Common Stock, no par value | 20000 | $0.00 | 90,170.0000 | 0 | 28.50% | 0.00% |
| June 23, 2023 | Insight Molecular Diagnostics Inc. | $IMDX | Last Andrew J. | Director | A | Option to Purchase Common Stock | 90000 | $0.00 | 90,000.0000 | 0 | 9999.99% | 0.00% |
| April 29, 2023 | BIO-RAD LABORATORIES, INC. | $BIO | Last Andrew J. | EVP, Chief Operating Officer | M | Bio-Rad A Common Stock | 1000 | $0.00 | 4,112.6151 | 29,785,000 | 32.13% | 0.00% |
| April 29, 2023 | BIO-RAD LABORATORIES, INC. | $BIO | Last Andrew J. | EVP, Chief Operating Officer | F | Bio-Rad A Common Stock | 346 | $450.79 | 3,766.6151 | 29,785,000 | 8.41% | 0.00% |
| April 29, 2023 | BIO-RAD LABORATORIES, INC. | $BIO | Last Andrew J. | EVP, Chief Operating Officer | M | Restricted Stock Units | 1000 | $0.00 | 1,000.0000 | 29,785,000 | 50.00% | 0.00% |